SaaS entity
Last mentioned: Jul 27, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: market-trends. IonQ is most often covered alongside Eli Lilly, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.9 for the same window. At 6, the average consequence score sits below the same-window beat average of 6.5. IonQ appears in 1 tracked SaaS story from March 4, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 SaaS stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering IonQ. Shared-story counts are live from our verified record — not editorial picks.
As market volatility persists in early 2026, analysts are identifying high-conviction growth opportunities in AI-integrated healthcare and specialized cloud infrastructure. Companies like Nebius and SoundHound AI are demonstrating explosive revenue trajectories, while Veeva Systems continues to dominate the vertical SaaS landscape for life sciences.
IonQ is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
